[ CYPHER CODE #1679 ]
The gut was always part of the bargain.
[ CYPHER CODE #1680 ]
The miracle got marketed faster than the warnings.
[ CYPHER CODE #1681 ]
Weight loss was the headline. Digestion was the footnote.
BRIEFING
Grant here. Ozempic has become a cultural phenomenon, and it's largely because it promised something America desperately wanted: weight loss without the misery of hunger, willpower, or constant food noise. And it definitely delivered, but not without a cost. Let’s break it down.
An eye-opening thread on X is exposing drugs like Ozempic and the real toll they take on the human body.
As the thread points out, GLP-1 drugs don’t just suppress appetite in some magical way. It does this through a process that goes against the human body's natural processes. Ozempic’s own prescribing information says it delays gastric emptying, which means food moves through the stomach more slowly. That’s part of why people feel fuller longer, but it also means the gut isn't functioning how it's meant to and thus can suffer some serious side effects.
The threat also points to the growing number of lawsuits tied to Ozempic and other GLP-1 drugs, especially cases involving gastroparesis, ileus, and intestinal obstruction. Drugwatch currently lists 3,636 personal injury lawsuits in MDL 3094 in the Eastern District of Pennsylvania as of May 2026, though these are allegations in active litigation, not final findings.
SOURCE
Ozempic now has 3,636 active lawsuits as of this month.
Most of them are for the same thing. stomach paralysis. Nobody told these people their gut was the most important conversation to have before starting.Here's what ozempic actually does in the gut.🧵— No filter Skin (@NoFilterSkin) May 9, 2026
It mimics GLP-1, a hormone that slows gastric emptying. that's the mechanism behind the appetite suppression.
Food moves slower. You feel full longer. You eat less. that part works. .— No filter Skin (@NoFilterSkin) May 9, 2026
The problem is the enteric nervous system, your gut's own brain, was not built to sustain that kind of override long term
— No filter Skin (@NoFilterSkin) May 9, 2026
Between 40 and 70% of people on these drugs report GI side effects. acid reflux. chronic diarrhea. constipation.
A 2023 JAMA study found nearly a fourfold increased risk of gastroparesis on GLP-1 agonists compared to other weight loss medications.— No filter Skin (@NoFilterSkin) May 9, 2026
ninefold increased risk of pancreatitis. gastroparesis means food sits in your stomach and does not move. full stop.
— No filter Skin (@NoFilterSkin) May 9, 2026
What nobody is talking about.
Research published in 2026 showed that the state of your gut microbiome before you start determines how well the drug works.People with gut dysbiosis, IBS, bloating, irregular bowel movements, lose less weight, see poorer blood sugar results.— No filter Skin (@NoFilterSkin) May 9, 2026
And experience more GI side effects. the drug does its job. The gut environment makes it harder for the body to respond.
Your microbiome predicted your outcome before you took a single dose.— No filter Skin (@NoFilterSkin) May 9, 2026
What makes it worse.
Starting on a gut that's already inflamed or dysbiotic. Not addressing the root cause first. No provider is asking: what does this person's gut actually look like before we slow their digestion down for months?that's the question that should come first.— No filter Skin (@NoFilterSkin) May 9, 2026
What i'd do instead before starting any GLP-1.
30 days minimum working on gut motility and microbiome diversity. Ginger tea, 1g, before meals daily. supports gastric emptying, not slowing it further.— No filter Skin (@NoFilterSkin) May 9, 2026
Cooked and cooled resistant starch, think rice and potatoes, 2 cups daily. feeds Akkermansia. 400mg magnesium glycinate at night. keeps motility moving. remove ultra-processed food entirely.
The emulsifiers are dismantling your gut lining while the drug slows everything down.— No filter Skin (@NoFilterSkin) May 9, 2026
If you're already on it, this is not a reason to stop without your doctor.
It's a reason to protect the gut you have right now.— No filter Skin (@NoFilterSkin) May 9, 2026
It's worth noting that beyond this thread, there’s also legitimate research behind the concerns.
A 2023 JAMA study found that GLP-1s used for weight loss were associated with higher risks of pancreatitis, bowel obstruction, and gastroparesis compared with bupropion-naltrexone. The study didn't state every user is at high risk, but it did make clear that rare gastrointestinal events are significant, especially when millions of people are taking these drugs.
Share your opinion
COMMENT POLICY: We have no tolerance for comments containing violence, racism, vulgarity, hard-core profanity, all caps, or discourteous behavior. Thank you for partnering with us to maintain a courteous and useful public environment!